The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.
Open accessAbstract
beta-Amyloid is a 39- to 43-amino-acid neurotoxic peptide that aggregates to form the core of Alzheimer disease-associated senile (amyloid) plaques. No satisfactory hypothesis has yet been proposed to explain the mechanism of beta-amyloid aggregation and toxicity. We present mass spectrometric and electron paramagnetic resonance spin trapping evidence that beta-amyloid, in aqueous solution, fragments and generates free radical peptides. beta-Amyloid fragments, at concentrations that previously have been shown to be neurotoxic to cultured neurons, can inactivate oxidation-sensitive glutamine synthetase and creatine kinase enzymes. Also, salicylate hydroxylation assays indicate that reactive oxygen species are generated by the beta-amyloid-(25-35) fragment during cell-free incubation. These results are formulated into a free radical-based unifying hypothesis for neurotoxicity of beta-amyloid and are discussed with reference to membrane molecular alterations in Alzheimer disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Aβ is reported to increase RS in neurons via multiple mechanisms, including direct Aβ-induced RS production, elevated NADPH oxidase activity, interaction with mitochondria-associated Aβ alcohol dehydrogenase, inhibition of cytochrome oxidase (respiratory complex IV), and by causing leakage of electrons from the mitochondrial electron transport chain (Hensley et al., 1994; Canevari et al., 1999; L”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Hensley et al., 1994
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Self-citationAssembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014
Oliver, C., Starke-Reed, P. E., Stadtman, E. R., Liu, G. J., Carney, J. M., & Floyd, R. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5144 · Cited by 771
Self-citationCarney, J. M., Starke-Reed, P. E., Oliver, C., Landum, R. W., Cheng, M. S., Wu, J., & Floyd, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3633 · Cited by 724
Self-citationFloyd, R. A., & Carney, J. M. (1992) · Annals of Neurology · doi:10.1002/ana.410320706 · Cited by 539
Self-citationβ-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease
Mattson, M. P., Barger, S. W., Cheng, B., Lieberburg, I. M., Smith‐Swintosky, V. L., & Rydel, R. E. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90009-b · Cited by 518
Self-citation
Flagged first, then by citations
Research works printed but not linked: 5
- [9]Oliver, C. N., Starke-Reed, P. E., Stadtman, E. R., Liu, G. J., Carney, J. M. & Floyd, R. A. (1990) Proc. Natl. Acad. Sci. USA 87, 5144–5147.
- [11]Miller, R. E., Hadenberg, R. & Gersham, H. (1978) Proc. Natl. Acad. Sci. USA 75, 1418–1422.
- [13]Janzen, E. G. (1980) in Free Radicals in Biology, ed. Pryor, W. A. (Academic, New York), Vol. 4, pp. 115-154.
- [19]Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Landum, R. W., Cheng, M. S., Wu, J. F. & Floyd, R. A. (1991) Proc. Natl. Acad. Sci. USA 88, 3633–3636.
- [27]Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A. & Markesbery, W. R. (1991) Proc. Natl. Acad. Sci. USA 88, 10540–10543.
Cited by
Sorted by citations
Items 601–700 of 1,000
Café, C., Torri, C., Bertorelli, L., Angeretti, N., Lucca, E., Forloni, G., & Marzatico, F. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12250-8 · Cited by 37
Sawmiller, D. R., Habib, A., Hou, H., Mori, T., Fan, A., Tian, J., Jin, Z., Giunta, B. N., Sanberg, P. R., Mattson, M. P., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.026 · Cited by 38
Self-citationRetractedKabiraj, P., Marin, J. E., Varela-Ramı́rez, A., & Narayan, M. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00159 · Cited by 36
Docosahexaenoic acid withstands the Aβ25-35-induced neurotoxicity in SH-SY5Y cells
Hashimoto, M., Katakura, M., Hossain, S., Rahman, A., Shimada, T., & Shido, O. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.11.005 · Cited by 36
Cis Carotenoids: Colorful Molecules and Free Radical Quenchers
Hernández‐Marín, E., Galano, A., & Martı́nez, A. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp401647n · Cited by 36
Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro
Wujek, J. R., Dority, M. D., Frederickson, R. C. A., & Brunden, K. R. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02020-9 · Cited by 36
Protective Effects of Pinostrobin on β-Amyloid-Induced Neurotoxicity in PC12 Cells
Xian, Y., Ip, S., Lin, Z., Mao, Q., Su, Z., & Lai, X. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9847-x · Cited by 35
Electrochemical and Conformational Consequences of Copper (CuI and CuII) Binding to β‐Amyloid(1–40)
Brzyska, M., Trześniewska, K., Wieckowska, A., Szczepankiewicz, A. A., & Elbaum, D. (2009) · ChemBioChem · doi:10.1002/cbic.200800732 · Cited by 35
Al‐Amiery, A. A., Kadhum, A. A. H., Obayes, H. R., & Mohamad, A. B. (2013) · Bioinorganic Chemistry and Applications · doi:10.1155/2013/354982 · Cited by 35
Yan, Y., Gong, K., Ma, T., Zhang, L., Zhao, N., Zhang, X., Tang, P., & Gong, Y. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.10.043 · Cited by 35
Briyal, S., Shepard, C., & Gulati, A. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.02.008 · Cited by 35
The Model Caenorhabditis elegans in Diabetes Mellitus and Alzheimer's Disease
Morcos, M., & Hutter, H. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0977 · Cited by 36
Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain
Makar, T. K., Cooper, A. J. L., Tofel-Grehl, B., Thaler, H. T., & Blass, J. P. (1995) · Neurochemical Research · doi:10.1007/bf01705539 · Cited by 35
Bhole, R. P., Chikhale, R. V., & Rathi, K. M. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.11.003 · Cited by 34
Takenouchi, T., & Munekata, E. (1998) · Peptides · doi:10.1016/s0196-9781(97)00377-x · Cited by 34
Mäkitie, L., Kanerva, K., Polvikoski, T. M., Paetau, A. E., & Andersson, L. C. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00334.x · Cited by 35
Tian, X., Wang, J., Dai, J., Yang, L., Zhang, L., Shen, S., & Huang, P. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.690797 · Cited by 34
Schrag, M., Sharma, S., Brown‐Borg, H. M., & Ghribi, O. (2007) · Hippocampus · doi:10.1002/hipo.20387 · Cited by 34
RetractedTherapeutic Targeting of the Endoplasmic Reticulum in Alzheimers Disease
Chadwick, W., Mitchell, N. A., Martin, B., & Maudsley, S. R. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015055 · Cited by 34
Floyd, R. A., Hensley, K., & Bing, G. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_28 · Cited by 34
Self-citationTransthyretin inhibition of amyloid beta aggregation and toxicity
Giunta, S., Valli, M. B., Galeazzi, R., Fattoretti, P., Corder, E. H., & Galeazzi, L. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2005.08.007 · Cited by 34
Untangling the pathophysio-chemistry of β-amyloid
Mattson, M. P. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb1195-926 · Cited by 34
Self-citationNeurodegeneration in Alzheimer disease
Kusiak, J. W., Izzo, J. A., & Zhao, B. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815217 · Cited by 35
Why therapies for Alzheimer’s disease do not work: Do we have consensus over the path to follow?
Amtul, Z. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.09.003 · Cited by 35
Zhang, J., Zhang, R., & Meng, X. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.08.037 · Cited by 33
Clementi, M. E., Martorana, G. E., Pezzotti, M., Giardina, B., & Misiti, F. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.03.006 · Cited by 33
Coordination of Zn 2+ and Cu 2+ to the membrane disrupting fragment of amylin
Rowińska‐Żyrek, M. (2016) · Dalton Transactions · doi:10.1039/c6dt00628k · Cited by 33
Mattson, M. P. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53014-2 · Cited by 33
Self-citationAluminum treatment induces nitric oxide synthase in the rat brain
Bondy, S. C., Liu, D., & Guo‐Ross, S. X. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(05)80008-7 · Cited by 33
The Amyloid Peptide and Its Precursor in Alzheimer's Disease
Octave, J. N. (1995) · Reviews in the Neurosciences · doi:10.1515/revneuro.1995.6.4.287 · Cited by 34
Increases in tissue levels of ubiquinone in association with peroxisome proliferation
Åberg, F. O., Zhang, Y., Teclebrhan, H., Appelkvist, E., & Dallner, G. (1996) · Chemico-Biological Interactions · doi:10.1016/0009-2797(95)03670-9 · Cited by 33
Hall, N. C., Carney, J. M., Cheng, M., & Butterfield, D. A. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00289-u · Cited by 33
Self-citationAmyloids: The History of Toxicity and Functionality
Yakupova, E. I., Bobyleva, L. G., Shumeyko, S. A., Vikhlyantsev, I. M., & Bobylev, A. G. (2021) · Biology · doi:10.3390/biology10050394 · Cited by 34
Asuni, A. A., Guridi, M., Sanchez, S., & Sadowski, M. J. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.08.006 · Cited by 34
Characterization of Mitochondrial Dysfunction in the 7PA2 Cell Model of Alzheimer's Disease
Jakovljevic, N. K., Magnifico, M. C., Arese, M., Meli, G., Forte, E., Lecci, A., Manca, A., Giuffrè, A., Mastronicola, D., Sarti, P., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130728 · Cited by 32
Protective effect of new S-acylglutathione derivatives against amyloid-induced oxidative stress
Pensalfini, A., Cecchi, C., Zampagni, M., Becatti, M., Favilli, F., Paoli, P., Catarzi, S., Bagnoli, S., Nacmias, B., Sorbi, S., et al. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.01.025 · Cited by 32
Liu, Q., Jiang, H., Wang, Y., Wang, L., Zhang, J., He, C., Shao, S., Zhang, T., Xing, J., & Liu, R. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.10.041 · Cited by 32
Zhang, S., & Janciauskiene, S. M. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4206 · Cited by 32
Kuperstein, F., Reiss, N. A., Koudinova, N. V., & Yavin, E. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00037.x · Cited by 32
Making models for Alzheimer's disease
Lamb, B. T. (1995) · Nature Genetics · doi:10.1038/ng0195-4 · Cited by 32
Early contribution of oxidative glycation in Alzheimer disease
Smith, M. A., Tabaton, M., & Perry, G. L. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)13100-1 · Cited by 32
Sun, Y., Wright, H. T., & Janciauskiene, S. M. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10144 · Cited by 32
The heat shock/oxidative stress connection
Pappolla, M. A., Sos, M., Omar, R. A., & Sambamurti, K. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815201 · Cited by 32
Book Review: Is Alzheimer’s Disease a Mitochondrial Disorder?
Cash, A., Perry, G. L., Ogawa, O., Raina, A. K., Zhu, X., & Smith, M. A. (2002) · The Neuroscientist · doi:10.1177/107385802236968 · Cited by 32
Rönnbäck, A., Pavlov, P. F., Mansory, M., Gonze, P., Marlière, N., Winblad, B. G., Graff, C., & Behbahani, H. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13410 · Cited by 32
Li, L., Du, J., Zou, L., Wu, T., Lee, Y.-W., & Kim, Y.-H. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/467245 · Cited by 31
RetractedYang, L., & Zeng, C. (2018) · Molecules · doi:10.3390/molecules23123122 · Cited by 31
Intersection between Redox Homeostasis and Autophagy: Valuable Insights into Neurodegeneration
Park, H., Kim, J., Shin, C., & Lee, S. (2021) · Antioxidants · doi:10.3390/antiox10050694 · Cited by 32
Efficacy and Safety of a Brain-Penetrant Biologic TNF-α Inhibitor in Aged APP/PS1 Mice
Ou, W., Ohno, Y., Yang, J., Chandrashekar, D. V., Abdullah, T., Sun, J., Murphy, R., Roules, G. C., Jagadeesan, N., Cribbs, D. H., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102200 · Cited by 31
Watanabe, T., Iwasaki, K., Ishikane, S., Naitou, T., Yoshimitsu, Y., Yamagata, N., Özdemir, M. B., Takasaki, K., Egashira, N., Mishima, K., et al. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0071648 · Cited by 31
Differentiation Increases the Resistance of Neuronal Cells to Amyloid Toxicity
Cecchi, C., Pensalfini, A., Liguri, G., Baglioni, S., Fiorillo, C., Guadagna, S., Zampagni, M., Formigli, L., Nosi, D., & Stefani, M. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9627-7 · Cited by 31
Leclerc, E., Sturchler, E., Vetter, S. W., & Heizmann, C. W. (2009) · Reviews in the Neurosciences · doi:10.1515/revneuro.2009.20.2.95 · Cited by 31
What Can Rodent Models Tell Us About Cognitive Decline in Alzheimer's Disease?
Davis, S., & Laroche, S. (2003) · Molecular Neurobiology · doi:10.1385/mn:27:3:249 · Cited by 32
Uric and 1-Methyluric Acids: Metabolic Wastes or Antiradical Protectors?
León‐Carmona, J. R., & Galano, A. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp209776x · Cited by 31
El‐Agnaf, O. M. A., Guthrie, D. J. S., Walsh, D. M., & Irvine, G. B. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2560560.x · Cited by 31
Smith, I. F., Boyle, J. P., Green, K. N., Pearson, H. A., & Peers, C. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02212.x · Cited by 32
Hoffmann, J., Pietrzik, C. U., Kummer, M. P., Twiesselmann, C., Bauer, C., & Herzog, V. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700311 · Cited by 31
Neuroimmunodegeneration: do neurons and T cells use common pathways for cell death?
Lynn, W. S., & Wong, P. K. Y. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.12.7672507 · Cited by 31
Barbalace, M. C., Zallocco, L., Beghelli, D., Ronci, M., Scortichini, S., Digiacomo, M., Macchia, M., Mazzoni, M. R., Fiorini, D., Lucacchini, A., et al. (2021) · Antioxidants · doi:10.3390/antiox10030421 · Cited by 31
Roles of Phase Separation for Cellular Redox Maintenance
Saito, Y., & Kimura, W. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.691946 · Cited by 30
Multhaup, G., Scheuermann, S., Schlicksupp, A., Simons, A., Strauss, M., Kemmling, A., Oehler, C., Cappai, R., Pipkorn, R., & Bayer, T. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00806-7 · Cited by 30
Badía, M.-C., Lloret, A., Giraldo, E., Dası́, F., González, G. O., Alonso, M.-D., & Viña, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120973 · Cited by 30
Rosales‐Corral, S., López-Armas, G. D. C., Cruz-Ramos, J. A., Melnikov, V., Tan, D., Manchester, L. C., Munoz, R., & Reiter, R. J. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/459806 · Cited by 30
EVALUATION OF HOW CIGARETTE SMOKE IS A DIRECT RISK FACTOR FOR ALZHEIMER'S DISEASE
Giunta, B. N., Deng, J., Jin, J., Sadic, E., Rum, S., Zhou, H., Sanberg, P. R., & Tan, J. (2012) · Technology & Innovation · doi:10.3727/194982412x13378627621752 · Cited by 30
Hirai, K., Hayako, H., Kato, K., & Miyamoto, M. (1998) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005296 · Cited by 30
Vascular nitric oxide may lessen Alzheimer's risk
McCarty, M. F. (1998) · Medical Hypotheses · doi:10.1016/s0306-9877(98)90066-4 · Cited by 30
Identification of amyloid-β binding sites using an antisense peptide approach
Milton, N. G. N., Mayor, N. P., & Rawlinson, J. (2001) · Neuroreport · doi:10.1097/00001756-200108080-00054 · Cited by 29
Lee, S. G., Lee, H., Nam, T. G., Eom, S. H., Heo, H. J., Lee, C. Y., & Kim, D. (2011) · Journal of Food Science · doi:10.1111/j.1750-3841.2010.02010.x · Cited by 29
Sreenivasachary, N., Kroth, H., Benderitter, P., Hamel, A., Varisco, Y., Hickman, D. T., Froestl, W., Pfeifer, A., & Muhs, A. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.02.001 · Cited by 29
Oh, Y., Kim, E. Y., Kim, Y., Jin, J., Jin, B. K., Jahng, G., Jung, M. H., Park, C., Kang, I., Ha, J., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.036 · Cited by 29
He, Y., Jia, K., Li, L., Wang, Q., Zhang, S., Du, J., & Du, H. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.119 · Cited by 29
Small, D. H. (1998) · Neurochemical Research · doi:10.1023/a:1022471729291 · Cited by 30
Brunelle, P., & Rauk, A. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4403 · Cited by 29
Lee, S., Bang, S. M., Hong, Y. K., Lee, J. H., Jeong, H., Park, S. H., Liu, Q. F., Lee, I., & Cho, K. S. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.018069 · Cited by 28
TEMPOL protects human neuroblastoma SH-SY5Y cells against ß-amyloid-induced cell toxicity
Chonpathompikunlert, P., Han, J., Toh, K., Isoda, H., & Nagasaki, Y. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.028 · Cited by 28
Protective effect ofRosa laevigataagainst amyloid beta peptide-induced oxidative stress
Choi, S. J., Kim, M. J., Heo, H. J., Kim, H. K., Hong, B.-S., Kim, C., Kim, B., & Shin, D. H. (2006) · Amyloid · doi:10.1080/13506120500535636 · Cited by 28
Louzada, P. R., Paula-Lima, A. C., Mello, F. G. D., & Ferreira, S. T. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01585-3 · Cited by 28
Transferrin neutralization of amyloid β 25–35 cytotoxicity
Giunta, S., Galeazzi, R., Valli, M. B., Corder, E. H., & Galeazzi, L. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.07.025 · Cited by 28
Perturbed Signal Transduction in Neurodegenerative Disorders Involving Aberrant Protein Aggregation
Mattson, M. P., & Sherman, M. Y. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:109 · Cited by 29
Self-citationCommentary: Aβ N- Terminal Isoforms: Critical contributors in the course of AD pathophysiology
Tekirian, T. L. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3209 · Cited by 28
Chiu, Y., Lee, C.-M., Lin, T., Lin, H.-Y., Lee, S.-Y., Mesri, M., Chang, K., Lin, J., Lee‐Chen, G., & Chen, C. (2018) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x18500799 · Cited by 27
Pérez‐González, A., & Galano, A. (2012) · International Journal of Quantum Chemistry · doi:10.1002/qua.24046 · Cited by 27
Oxidative Alterations in Neurodegenerative Diseases
Markesbery, W. R., Montine, T. J., & Lovell, M. A. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-106-0_2 · Cited by 27
Inhibition of amyloid-β-induced cell death in human brain pericytes in vitro
Rensink, A. A. M., Verbeek, M. M., Otte‐Höller, I., ten Donkelaar, H. J., de Waal, R. M. W., & Kremer, B. P. H. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03218-3 · Cited by 27
Apoptosis in Neurodegenerative Diseases
Nishimoto, I., Okamoto, T., Giambarella, U., & Iwatsubo, T. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61064-9 · Cited by 27
Will antioxidants fulfill their expectations for the treatment of Alzheimer disease?
Rottkamp, C. A., Nunomura, A., Hirai, K., Sayre, L. M., Perry, G. L., & Smith, M. A. (2000) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00124-x · Cited by 27
Time-course of oxidation of lipids in human cerebrospinal fluidin vitro
Arlt, S., Finckh, B., Beisiegel†, U., & Kontush, A. (2000) · Free Radical Research · doi:10.1080/10715760000300111 · Cited by 27
A review study on the effect of zinc on oxidative stress-related neurological disorders
Vali, R., Shirvanian, K., Farkhondeh, T., Aschner, M., Samini, F., & Samarghandian, S. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127618 · Cited by 27
Bilingualism as a Contributor to Cognitive Reserve: What it Can do and What it Cannot do
Berkes, M., & Bialystok, E. (2022) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175221091417 · Cited by 26
Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease
Susmitha, G., & Kumar, R. K. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109478 · Cited by 27
Semidalas, C. E., Semidalas, E. C., Matsoukas, M., Nixarlidis, C., & Zoumpoulakis, P. G. (2016) · Medicinal Chemistry Research · doi:10.1007/s00044-016-1689-5 · Cited by 26
Yang, Y., & Gao, Y. Q. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp502169b · Cited by 26
Does human βA4 exert a protective function against oxidative stress in Alzheimer’s disease?
Berthon, G. (2000) · Medical Hypotheses · doi:10.1054/mehy.1999.0924 · Cited by 26
Waiker, D. K., Verma, A., Saraf, P., Gajendra, T. A., Krishnamurthy, S., Chaurasia, R. N., & Shrivastava, S. K. (2023) · ACS Omega · doi:10.1021/acsomega.2c08061 · Cited by 25
Shaked, G. M., Chauv, S., Ubhi, K. K., Hansen, L. A., & Masliah, E. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.06997.x · Cited by 25
Theoretical study on the investigation of antioxidant properties of some hydroxyanthraquinones
Işın, D. Ö. (2016) · Molecular Physics · doi:10.1080/00268976.2016.1248514 · Cited by 25
Analysis of post-translational modifications in Alzheimer's disease by mass spectrometry
Kelley, A. R., Bach, S. B. H., & Perry, G. L. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.11.002 · Cited by 25
Francisco‐Márquez, M., Aguilar-Fernández, M., & Galano, A. (2015) · Computational and Theoretical Chemistry · doi:10.1016/j.comptc.2015.09.025 · Cited by 25
Anti-inflammatory substances – a new therapeutic option in Alzheimer's disease
Hüll, M. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01339-2 · Cited by 27
Free Radicals in the Neurotoxic Actions of β‐Amyloida
Richardson, J. S., Zhou, Y., & Kumar, U. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34446.x · Cited by 25
Metadata
- Authors
- Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A.
- Affiliations
- University of Kentucky (US)
- Department of Chemistry, University of Kentucky, Lexington 40506.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1994-04-12
- Volume
- 91
- Issue
- 8
- Pages
- 3270-3274
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC43558
- OpenAlex
- W2070117026
- Cited by
- 1,086
- References
- 23
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 20 · 2023: 16 · 2022: 21 · 2021: 26 · 2020: 15 · 2019: 18 · 2018: 26 · 2017: 15 · 2016: 23 · 2015: 27 · 2014: 26 · 2013: 32 · 2012: 34
- FWCI
- 35.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Foundation (9108764)
- Glenn Foundation for Medical Research
- Fondation pour la Recherche Médicale
- National Institutes of Health (AG-10836)
- National Institute on Aging (AG 09690, P01AG010836, R01AG009690, AG 10836)
- Office of Naval Research
- National Institute of Neurological Disorders and Stroke (R01NS023307, NS-23307)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- amyloid-beta, amyloid fibril formation, neurotoxicity, free radicals, reactive oxygen species, glutamine synthetase, creatine kinase, salicylate hydroxylation, amyloid plaques, Alzheimer's disease, peptide fragmentation, membrane alterations
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Chromatography, High Pressure Liquid, Electron Spin Resonance Spectroscopy, Free Radicals, Gas Chromatography-Mass Spectrometry, Molecular Sequence Data, Neurotoxins, Salicylates, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review